MEDICATION ADHERENCE COMPARING TOBRAMYCIN INHALATION POWDER AND SOLUTION IN PATIENTS WITH CYSTIC FIBROSIS USING THE DUTCH PHARMO DATABASE NETWORK

被引：0
|
作者：
Overbeek, J. [2 ]
Kuiper, J. [2 ]
Evers, K. [3 ]
Putzeist, M. [3 ]
Mastoridis, P. [1 ]
Ong, S. H. [4 ]
Herk-Sukel, M. [2 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] PHARMO Inst, Utrecht, Netherlands
[3] Novartis Pharma BV, Arnhem, Netherlands
[4] Novartis Pharma AG, Basel, Switzerland
来源：
PEDIATRIC PULMONOLOGY | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
460
引用
收藏
页码：365 / 365
页数：1
相关论文
共 50 条
  • [1] Tobramycin Inhalation Powder Is As Effective As Tobramycin Inhalation Solution In Patients With Cystic Fibrosis: A Subgroup Analysis Of The Eager Trial
    Konstan, M. W.
    Parkins, M.
    Angyalosi, G.
    Higgins, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [2] POPULATION PHARMACOKINETICS OF TOBRAMYCIN INHALATION POWDER IN CYSTIC FIBROSIS PATIENTS
    Wu, K.
    Carter, A.
    Geller, D.
    Sahasranaman, S.
    PEDIATRIC PULMONOLOGY, 2010, : 306 - 307
  • [3] TOBRAMYCIN INHALATION POWDER VS TOBRAMYCIN INHALATION SOLUTION FOR CYSTIC FIBROSIS: RESPONSE BY AGE GROUP IN THE EAGER TRIAL
    Geller, D. E.
    Nasr, S.
    Piggott, S.
    Angyalosi, G.
    Higgins, M.
    PEDIATRIC PULMONOLOGY, 2011, : 337 - 338
  • [4] Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature
    Hagerman, Jennifer K.
    Knechtel, Stephanie A.
    Klepser, Michael E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (04) : 467 - 475
  • [5] Mortality of cystic fibrosis patients treated with tobramycin solution for inhalation
    Rothman, KJ
    Wentworth, CE
    EPIDEMIOLOGY, 2003, 14 (01) : 55 - 59
  • [6] Tobramycin Inhalation Powder in Cystic Fibrosis Patients: Response by Age Group
    Geller, David E.
    Nasr, Samya Z.
    Piggott, Simon
    He, Ellie
    Angyalosi, Gerhild
    Higgins, Mark
    RESPIRATORY CARE, 2014, 59 (03) : 388 - 398
  • [7] EFFECT OF TOBRAMYCIN INHALATION SOLUTION ON MORTALITY IN SUBGROUPS OF PATIENTS WITH CYSTIC FIBROSIS
    Latremouille-Viau, D.
    Sawicki, G. S.
    Zhang, J.
    von Wartburg, M.
    Signorovitch, J.
    Wu, E. Q.
    Shi, L.
    PEDIATRIC PULMONOLOGY, 2011, : 346 - 346
  • [8] Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution
    Sawicki, Gregory S.
    Signorovitch, James E.
    Zhang, Jie
    Latremouille-Viau, Dominick
    von Wartburg, Markus
    Wu, Eric Q.
    Shi, Lizheng
    PEDIATRIC PULMONOLOGY, 2012, 47 (01) : 44 - 52
  • [9] Population Pharmacokinetics of Tobramycin Inhalation Solution in Pediatric Patients With Cystic Fibrosis
    Wang, Xinting
    Koehne-Voss, Stephan
    Anumolu, SivaNaga S.
    Yu, Jing
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (11) : 3402 - 3409
  • [10] Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and cough
    Meerburg, Jennifer J.
    Albasri, Mehdi
    van der Wiel, Els C.
    Andrinopoulou, Eleni-Rosalina
    van der Eerden, Menno M.
    Majoor, Christof J.
    Arets, Hubertus G. M.
    Heijerman, Harry G. M.
    Tiddens, Harm A. W. M.
    PEDIATRIC PULMONOLOGY, 2019, 54 (11) : 1794 - 1800
12345